Marvell Technology (MRVL) stock is trading up approximately 17% on Friday morning after delivering a stronger-than-expected Q4 fiscal 2026 report and issuing forward guidance that electrified investors. The company posted adjusted EPS of $0.80, beating the $0.79 consensus, while revenue of $2.219B cleared the $2.207B estimate. Management raised the ante further on the earnings call, guiding for overall fiscal 2027 revenue to grow more than 30% year-over-year, approaching $11B, and projecting data center revenue to grow close to 50% in fiscal 2028.
Key Drivers of the MRVL Stock Move
- Catalyst: Q4 beat on EPS and revenue combined with a Q1 outlook of $2.28B-$2.52B in sales and management commentary flagging that Marvell now expects to supply DCI modules to all five major US hyperscalers this year, with the Celestial AI CPO business on track for a $500M annualized run rate by Q4 FY28.
- Bull Case: AI infrastructure spending shows no sign of decelerating. The hyperscaler customer diversification is a major de-risking story. Interconnect is guided to grow more than 50% year-over-year. Multiple analyst upgrades on the back of the print add institutional tailwind.
- Bear Case: Shares were already down roughly 13% year-to-date coming into earnings, and remain well below their 2025 highs. The Celestial AI acquisition closed only in early February 2026, and meaningful revenue contribution is not expected until 2028. Macro headwinds (rising Treasury yields, Iran geopolitical risk) weighed on the semiconductor sector throughout February and early March.
Marvell enters the post-earnings period in a constructively improved but not risk-free position. The company’s long-cycle data center story is gaining credibility, but execution risk tied to new customer ramps and the Celestial AI integration remains elevated. March has historically been a weak seasonal month for the stock, and the broader macro backdrop is complicated by geopolitical tensions driving oil and yields higher. Investors taking fresh positions at current levels are pricing in significant AI-driven execution ahead.
MRVL Smart Money Activity
Insider activity has been largely administrative: stock appreciation right conversions and modest open-market sells by the EVP & CLO (Mark Casper sold ~$465K in January) and RSU vestings for CEO Matthew Murphy and COO Chris Koopmans in line with routine schedules. No large discretionary insider buys have been filed recently. On the government side, congressional trading has been limited and mixed, with small purchases by Democratic members (Valerie Hoyle, Ro Khanna) and sales by Republican Rep. Jefferson Shreve through 2025. No congressional trades have been reported in 2026. There is no strong directional signal from either insiders or legislators at this time.
MRVL Unusual Options
Pre-earnings flow on March 4-5 was notably heavy and skewed to put selling and defensive positioning. The single largest trade was a $1.9M bullish Mar 20 $80 PUT block (sold at bid, suggesting a premium-collection bet that MRVL would hold above $80 into expiration). A $1.1M Jun 18 $80 PUT trade and a $1.1M Jan 2028 $60 PUT were also tagged bullish, pointing to larger players either hedging long stock or expressing long conviction. Post-earnings today (Mar 6), call flow has turned aggressively bullish: a $620.9K sweep on the Mar 20 $92 CALL and a $234.1K sweep on the Jun 2027 $40 CALL (deep ITM, likely a synthetic long) stand out. A $116.6K bullish sweep on the Mar 13 $96 CALL suggests traders are positioning for continued upside through next week’s expiration.
MRVL Analyst Focus
Today’s earnings report triggered a wave of analyst upgrades and higher price targets. B of A Securities upgraded the stock to Buy, raising its target from $90 to $110, while Benchmark moved from Hold to Buy with a $130 target. KGI Securities also upgraded the stock to Outperform with a $110 target. Several firms maintained bullish ratings while lifting targets, including Rosenblatt ($115 → $140), Stifel ($114 → $120), and RBC Capital ($105 → $115). The only more cautious view came from Morgan Stanley, which maintained Equal-Weight and raised its target from $95 to $103. Overall, today’s updates place the median price target around $115, with Morgan Stanley representing the main bear-case among major firms.
MRVL Seasonality
Based on data since January 2015 (12 samples per month), March is historically one of the weakest months for MRVL: only 42% of March periods have closed positive, with an average return of -2.6%. That compares unfavorably to strong seasonal months like November (82% positive, +10.8% avg) and May (82% positive, +9.1% avg). January (75% positive, +3.5%) and July (64% positive, +6.0%) are also seasonally constructive. The current post-earnings rally is running directly against the typical March headwind, which is worth monitoring as the initial momentum fades.
MRVL Relative Performance
Heading into today’s print, MRVL was sitting at a yearly relative performance percentile of approximately 62 vs. its technology sector peers, meaning it was outperforming roughly 62% of the sector on a trailing one-year basis. That reading had declined sharply from ~72 in early December 2025 to a trough near 50 in early February 2026 (around the time the Celestial AI acquisition closed and multiple analysts cut targets), before recovering into the low 60s through February and early March. Today’s move should push the relative performance percentile meaningfully higher if the gain holds.
Market Update Into September 7th: Inflation Data Incoming